title: Retrospective study comparing the pathophysiology of antibiotic-treated and untreated Escherichia coli- and Staphylococcus aureus-infused baboons.
abstract: Escherichia coli and Staphylococcus aureus are the most common pathogens encountered in septic shock. This is a descriptive study in which the pathophysiologic response to infusions of LD100 concentrations of E. coli and S. aureus are staged and compared. Equivalent concentrations of both organisms were infused over a 2 hr period into antibiotic-treated and untreated animals with the following results: 1) The apparent clearance of E. coli was less than that of S. aureus over the 2-hr infusion period, but far greater during the next 8 hr in both antibiotic-treated and untreated animals. Thus the clearance of E. coli fits a one-compartment (intravascular), and that of S. aureus fits a two-compartment (intra- and extravascular) model. 2) The intensity of the cardiovascular, temperature, and metabolic response to E. coli was greater, whereas that of the disseminated intravascular coagulant (DIC) response to S. aureus was greater. We conclude, therefore, that the response to E. coli consists of four stages with no invasion and colonization of tissues, whereas the response to S. aureus consists of two stages with invasion and colonization of tissues.
authors.affiliation: Human Medical University, Changsha, China.
authors.forename: S
authors.initials: S
authors.lastname: He
authors.forename: L
authors.initials: L
authors.lastname: Hinshaw
authors.forename: T
authors.initials: T
authors.lastname: Emerson
authors.forename: S
authors.initials: S
authors.lastname: Kosanke
authors.forename: G
authors.initials: G
authors.lastname: White
authors.forename: M M
authors.initials: MM
authors.lastname: Randolph
authors.forename: A K
authors.initials: AK
authors.lastname: Chang
authors.forename: M
authors.initials: M
authors.lastname: Duerr
authors.forename: G
authors.initials: G
authors.lastname: Peer
authors.forename: R
authors.initials: R
authors.lastname: Passey
mesh_terms: D000818:Animals; D002443:Ceftriaxone / Q000627:therapeutic use; D004195:Disease Models, Animal; D004927:Escherichia coli Infections / Q000188:drug therapy / Q000209:etiology / Q000503:physiopathology*; D005839:Gentamicins / Q000627:therapeutic use; D006439:Hemodynamics; D006487:Hemostasis; D007668:Kidney / Q000473:pathology; D008168:Lung / Q000382:microbiology / Q000473:pathology; D010215:Papio; D012772:Shock, Septic / Q000209:etiology / Q000503:physiopathology; D013203:Staphylococcal Infections / Q000188:drug therapy / Q000209:etiology / Q000503:physiopathology*
chemical_list: D005839:Gentamicins; D002443:Ceftriaxone